Purchase Order HHSN261201700375P
Award Date 7/5/17
Potential Completion Date 7/5/22
Potential Value $146K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) to Illumina, Inc. for $17,598.18. The contract does not have a set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying consumables and support services, to support genomic sequencing and analysis for research and diagnostic applications across several...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $147,003.32 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $190,561.89 contract is for Illumina's sequencing services and is not set-aside. Illumina has provided similar sequencing goods and services to support research and diagnostics for various federal...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,987.33 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support, and maintenance services. This award does not have a small business set-aside designation....
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
- This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $6,418.66 contract is for the provision of various Illumina sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems, along with related consumables, sample preparation kits, and support services. Illumina has previously served as a subcontractor on federal contracts supporting genomic...
- This $125,814.00 firm fixed price Purchase Order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for a NovaSeq Service Agreement, providing maintenance and support services for a NovaSeq sequencing system to be used at the NIH facility in Research Triangle Park, North Carolina. This...
- This is a $28,749.60 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Through this award, Illumina will provide the NCI with a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits,...
- This is a firm fixed price delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. for $91,615.99. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This is not a set-aside contract. Illumina has...